Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy

NCT03674671 is registered in ClinicalTrials.gov with University of Ottawa as lead sponsor.

NCT NCT03674671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03674671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy
Lead sponsor
University of Ottawa
Phase
Phase 3
Overall status
Suspended
Start date
October 29, 2018
Completion date
December 31, 2025
Enrollment
240 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, depressive disorder, major